Weight loss
FAQ
For people who are overweight or obese, Semaglutide is a beneficial FDA-approved treatment option. Patients with difficulty controlling their food intake often benefit from the Semaglutide program. People suffering from obesity (BMI >30) or excess weight (BMI >27) may benefit from treatment.
Patients with medullary thyroid cancer (MTC) or MEN 2 (endocrine disorders) should not use Semaglutide. People with diabetes should not take Semaglutide with type I diabetes.
The length of your Semaglutide program will be determined by the amount of weight you would like to lose.
In most cases, patients do not experience uncontrolled hunger. You will be able to feel satisfied even with smaller portions. Although we recommend a healthy diet, there are no specific food restrictions.
